no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A shared basis for overlapping immunopathologies in giant cell arteritis and polymyalgia rheumatica
|
Mackie, Sarah L |
|
|
3 |
12 |
p. e826-e829 |
article |
2 |
COVID-19 in systemic vasculitis and polymyalgia rheumatica: who is at risk of poor outcomes?
|
Monti, Sara |
|
|
3 |
12 |
p. e823-e824 |
article |
3 |
Diagnostic accuracy of vascular ultrasound in patients with suspected giant cell arteritis (EUREKA): a prospective, multicentre, non-interventional, cohort study
|
Chrysidis, Stavros |
|
|
3 |
12 |
p. e865-e873 |
article |
4 |
Disease stratification in giant cell arteritis to reduce relapses and prevent long-term vascular damage
|
Tomelleri, Alessandro |
|
|
3 |
12 |
p. e886-e895 |
article |
5 |
Giant cell arteritis: one size does not fit all
|
The Lancet Rheumatology, |
|
|
3 |
12 |
p. e819 |
article |
6 |
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19
|
Della-Torre, Emanuel |
|
|
3 |
12 |
p. e829-e831 |
article |
7 |
Juvenile systemic lupus erythematosus presenting as retinal vasculitis
|
Roongta, Rashmi |
|
|
3 |
12 |
p. e896 |
article |
8 |
New insights into the pathogenesis of giant cell arteritis: are they relevant for precision medicine?
|
Ciccia, Francesco |
|
|
3 |
12 |
p. e874-e885 |
article |
9 |
Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study
|
Sattui, Sebastian E |
|
|
3 |
12 |
p. e855-e864 |
article |
10 |
Pain levels and associated factors in the Scleroderma Patient-centered Intervention Network (SPIN) cohort: a multicentre cross-sectional study
|
Lee, Yvonne C |
|
|
3 |
12 |
p. e844-e854 |
article |
11 |
Prioritising pain in patients with systemic sclerosis
|
Baerwald, Christoph |
|
|
3 |
12 |
p. e821-e823 |
article |
12 |
Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS)
|
Bellando-Randone, Silvia |
|
|
3 |
12 |
p. e834-e843 |
article |
13 |
Research in Brief
|
Thorley, Jennifer |
|
|
3 |
12 |
p. e833 |
article |
14 |
Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies
|
Sciascia, Savino |
|
|
3 |
12 |
p. e832 |
article |
15 |
Scienced by blinding: ultrasound for giant cell arteritis
|
Mackie, Sarah L |
|
|
3 |
12 |
p. e824-e826 |
article |
16 |
Systemic sclerosis: what's in a name?
|
Pauling, John D |
|
|
3 |
12 |
p. e820-e821 |
article |